partially supported by NIH funding R01 CA095071,CA79716,and CA75389 to XX from NCI,NIH;seed funding from Sylvester Comprehensive Cancer Center,University of Miami.
Taxanes,including paclitaxel,docetaxel,and cabazitaxel,are key agents in cancer treatment,often used as frontline chemotherapy drugs in combination with other agent(s)(commonly carboplatin)and as second-line treatment...
Paclitaxel,a tetracyclic diterpenoid,has garnered attention for its potent anti-cancer properties and intricate molecular structure,making it a significant target for chemical synthesis and biosynthesis[1].However,its...
This work was supported by the Georgia Research Alliance(Distinguished Investigator award to HF);the NCI Emory Lung Cancer SPORE Career Enhancement Program(P50CA217691 to XM);the Imagine,Innovate and Impact(I3)Funds from the Emory School of Medicine;and through the Georgia CTSA NIH award(UL1-TR002378)and Winship Cancer Institute(NIH 5P30CA138292).
Ovarian cancer is one of the most common gynecologic malignancies in women and has a poor prognosis.Taxanes are a class of standard first-line chemotherapeutic agents for the treatment of ovarian cancer.However,tumor-...
National Key New Drug Creation Special Programs(No. 2017ZX09304-021);Science and Technology Plan of Suzhou(No. SYSD2017151)
To the Editor:Gastric cancer is one of the most commonly diagnosed cancers in the world.For patients with a pathological tumor-node-metastasis stage of II or III,postoperative adjuvant chemotherapy is generally requir...
The means of cancer treatment and the understanding of chemotherapeutic drugs have made continuous progress in the past few decades. Chemotherapy is a basic and widely useful therapeutic method, and various therapeuti...
Background:Taxanes are an essential class of antineoplastic agents used to treat various cancers and are a fundamental cause of hypersensitivity reactions.In addition,other adverse events,such as bone marrow toxicity ...
Aim:We reviewed the radiographic response of three patients with metastatic castration-resistant prostate cancer treated with CRXL301,a docetaxel nanoparticle.For these three patients,we isolated and analyzed circulat...
funding from Breast Cancer Campaign UK for a grant to support this work(HMC).
Background:In search of potential biomarkers of drug responsiveness the tumour suppressor PLK2 has been identified as a mediator of taxane sensitivity in some tumour types,based on its role of G2M checkpoint regulatio...
the following grants: National Institutes ofHealth/National Cancer Institute (NIH/NCI) RO1 CAI88609, Department of Defense W81XWH-15-1-0439, W81XWH-16-1-0317, and W81XWH-14-1-0485;National Natural Science Foundation of China Project 81430087.
The development and progression of metastatic castration-resistant prostate cancer is the major challenge in the treatment of advanced prostate cancer. The androgen receptor signaling pathway remains active in metasta...
Cabazitaxel is a second-generation taxane with promising anti-tumor activity and is approved for treating hormone-refractory metastatic prostate cancer previously treated with docetaxel. Although first-generation taxa...